Shandong Weigao Group Medical Polymer Co stock analysis
Shandong Weigao Group Medical Polymer Co (SHWGF) Stock Price & Analysis
SHWGF Stock Chart & Stats
- Day’s Range
- $0.41 - $0.44
- 52-Week Range
- $0.38 - $0.76
- Previous Close
- $0.44
- Volume
- N/A
- Average Volume (3M)
- 400
- Market Cap
- $1.93B
- Enterprise Value
- $11.73B
- Total Cash (Recent Filing)
- $8.92B
- Total Debt (Recent Filing)
- $4.96B
- Price to Earnings (P/E)
- 9.5
- Beta
- 0.33
- Next Earnings
- Mar 30, 2027 (Est.)
- EPS Estimate
- 0.02
- Last Dividend Ex-Date
- Oct 23, 2026
- Dividend Yield
- 4.91%
Bulls Say, Bears Say
Bulls Say
Recurring Consumables Demand
The company serves routine clinical workflows with single-use products that require repeated replenishment. This recurring volume-based model can support durable demand as hospital utilization and patient volumes generate ongoing purchases across infusion, blood-related and other medical consumable categories.
Conservative Leverage
Conservative leverage gives the company financial flexibility while operating conditions are weaker. A stable capital structure reduces the burden of interest and refinancing obligations, helping preserve capacity to fund operations, maintain its product platform and respond to changes in healthcare procurement demand.
Positive Cash Generation
Continued positive operating and free cash flow indicates that the business still converts its established operations into funding. Although recent momentum has softened, ongoing cash generation can support working capital, product development and other corporate needs without relying entirely on external financing.
Bears Say
Sharp Revenue Contraction
The steep 2025 revenue decline signals a material weakening in demand, sales execution or procurement conditions relative to the prior base. If sustained, lower revenue would reduce operating scale and make it harder to absorb fixed costs, support investment and restore historical growth.
Long-term Margin Compression
Multi-year deterioration in both gross and net margins shows that profitability has become less resilient. Persistent compression can limit internal reinvestment and reduce earnings quality, while indicating that product mix, pricing or operating efficiency has not preserved the company’s earlier margin structure.
Weaker Free Cash Flow Momentum
The decline in free cash flow means less cash is being generated from the business than in the preceding period, even though absolute generation remains positive. Continued weakening would reduce financial flexibility and could constrain investment, shareholder distributions or the ability to absorb further operating pressure.
Shandong Weigao Group Medical Polymer Co News
SHWGF FAQ
What was Shandong Weigao Group Medical Polymer Co’s price range in the past 12 months?
What is Shandong Weigao Group Medical Polymer Co’s market cap?
When is Shandong Weigao Group Medical Polymer Co’s upcoming earnings report date?
How were Shandong Weigao Group Medical Polymer Co’s earnings last quarter?
Is Shandong Weigao Group Medical Polymer Co overvalued?
Does Shandong Weigao Group Medical Polymer Co pay dividends?
What is Shandong Weigao Group Medical Polymer Co’s EPS estimate?
How many shares outstanding does Shandong Weigao Group Medical Polymer Co have?
What happened to Shandong Weigao Group Medical Polymer Co’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Shandong Weigao Group Medical Polymer Co?
What is the TipRanks Smart Score and how is it calculated?
Shandong Weigao Group Medical Polymer Co Stock Smart Score
Company Description
Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Company Limited, founded in 2000 and situated in Weihai, People's Republic of China, specializes in the research, development, production, and distribution of disposable medical devices across mainland China. The company structures its extensive operations into several core divisions, including Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and other specialized segments. Its comprehensive product range covers a vast array of essential healthcare items. This includes devices for both vascular and non-vascular access, such as infusion sets, syringes, and specialized puncture needles, alongside various clinical collection kits. Shandong Weigao also provides solutions for wound care, offering sutures, healing dressings, cleaning products, and support devices for non-vascular catheters. In the realm of blood management, it supplies equipment for collection, storage, separation, and sterilization. The company is also a manufacturer of prefilled and pre-flush syringes, as well as instruments for blood collection and glucose monitoring. Its portfolio further extends to anesthesia consumables (general, local, and auxiliary), intensive care unit (ICU) equipment, and tools for both open and minimally invasive surgical procedures. Beyond disposables, the firm is a key producer of orthopedic devices, instruments for tumor and blood vessel interventions, and advanced medical components such as implantation materials and artificial organs. It also ventures into industrial manufacturing, producing medical-grade PVC granules, various plastic packaging materials, carton boxes, automated industrial equipment and parts, molds, and hemodialysis machines, encompassing Type I, Type II, and Type III medical devices. In addition to its manufacturing activities, Shandong Weigao offers a range of supporting services. These include finance leasing and factoring, wholesale distribution of Type I, surgical, and other disposable medical products. The company also provides asset management, enterprise consulting, management advisory, and comprehensive logistics and storage solutions, while actively exporting its products to international markets. Operating under recognized brands like Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing, the company serves a diverse clientele that includes hospitals, blood banks, various other medical facilities, and a broad network of distributors.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Rinan Cong
- Employees
- 13,310
- Website
- www.weigaogroup.com
- Address
- 1 Weigao Road, Weihai, SD, 264210, CN
Shandong Weigao Group Medical Polymer Co (SHWGF) Earnings & Revenues
SHWGF Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 12 | 6 | 4 |
| Technical Analysis | 3 | 6 | 1 |
| Moving Averages | 9 | 0 | 3 |
